Article
An MLL-Independent Function of Menin Promotes Resistance to MAPK-Targeted Therapy
2026-08-26
Abstract excerpt
BRAF mutant colorectal cancer (CRC) remains difficult to treat despite the clinical use of combined BRAF and EGFR inhibition, highlighting a need to define tumour-intrinsic mechanisms that limit therapeutic response. Here, using genome-wide CRISPR-Cas9 screening in BRAF-mutant CRC cells, we identify MEN1, encoding the chromatin-associated protein Menin, as a selective determinant of sensitivity to combined encoraf...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1edc4ecb-6913-5f14-a366-399204537536
- DOI
- 10.64898/2026.08.24.746076
